euro adhoc: Mergers - Acquisitions - Takeovers
Entry of transfer resolution of
Bayer Schering Pharma AG in Commercial Register
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
Sqeeze-out
25.09.2008
The resolution passed by the general meeting on January 17, 2007, on the transfer of the shares held by the remaining shareholders (minority shareholders) of Bayer Schering Pharma AG to Bayer Schering GmbH (principal shareholder) for an appropriate cash consideration in the amount of EUR 98.98 per share was today recorded in the company's record in the Commercial Register of the local court of Charlottenburg.
With entry of the transfer resolution in the Commercial Register all shares of the minority shareholders of Bayer Schering Pharma AG have effectively passed by operation of law to Bayer Schering GmbH. Pursuant to this, the shares held by minority shareholders substantiate exclusively entitlement to the aforementioned cash consideration.
Bayer Schering Pharma AG will shortly be withdrawn from the stock exchange.
Berlin, September 25, 2008
The Board of Management Bayer Schering Pharma AG
end of announcement euro adhoc
Further inquiry note:
Denise Rennmann
Head of Global Media Relations
Bayer Schering Pharma AG
Tel.: +49(0)30 468 12066
Fax: +49(0)30 468 18195
E-Mail: denise.rennmann@bayerhealthcare.com
Branche: Pharmaceuticals
ISIN: DE0007172009
WKN: 717200
Index: CDAX
Börsen: Börse Berlin / regulated dealing
Börse Hamburg / regulated dealing
Börse Stuttgart / regulated dealing
Börse Düsseldorf / regulated dealing
Börse Hannover / regulated dealing
Börse München / regulated dealing
Börse Frankfurt / regulated dealing/general standard